e.g., HRA000087; HRA000150
HRA000912
Title:
Targeted-NGS of circulating tumor DNA, bone marrow and peripheral blood mononuclear cells in pediatric AML
Release date:
2021-06-10
Description:
The aim of the study was to validate the diagnostic role of circulating tumor DNA (ctDNA) in genetics aberration on basis of next-generation sequencing (NGS) in pediatric acute myeloid leukemia (AML).Bone marrow (BM) and peripheral blood (PB) were collected from 20 AML children at the time of initial diagnosis, and ctDNA sample was isolated from PB. Detection of mutation was performed on ctDNA, BM and peripheral blood mononuclear cell (PBMC) by NGS based on a 185-gene panel.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
acute myeloid leukemia
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Pediatric Blood Diseases Center
Contact person:
Zhang Yingchi
Email:
zhangyingchi@ihcams.ac.cn
Description:
Established in 1996, the Pediatric Blood Diseases Center is a research-oriented medical center which focuses on childhood leukemia and childhood bone marrow hematopoietic failure. At the same time, the diagnosis of rare and difficult miscellaneous childhood hematological diseases and the treatment of critical childhood hematological diseases are also unique. The diagnosis and treatment level of congenital bone marrow failure, myelodysplastic syndrome, and childhood myeloproliferative tumor (childhood chronic myeloid leukemia, juvenile chronic myelomonocytic leukemia) is in the leading position in China. Nowadays, the etiological diagnosis and hematopoietic stem cell transplantation (HSCT) treatment of rare childhood hematologic diseases have been fully carried out in our center.
Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
HRI111828557279maleHRS180263180502525B2no
HRI111828557279maleHRS180264180502525T3no
HRI111828557279maleHRS180300HB15JXEQ00024no
HRI111829556219femaleHRS180265180502526B2no
HRI111829556219femaleHRS180267180502526T3no
HRI111829556219femaleHRS180297HB15JXEQ00026no
HRI111830553517femaleHRS180268180502527B2no
HRI111830553517femaleHRS180269180502527T3no
HRI111830553517femaleHRS180298HB15JXEQ00714no
HRI111831559725maleHRS180270180502528T3no
Showing 1 to 10 of 60 rows rows per page
Run accession
Files
Experiment
Experiment title
Platform
Sample
Run accession
Files
Experiment
Experiment title
Platform
Sample
HRR243901HRR243901_f1.fastq.gz (3.61 GB)HRX202203180501817B2Illumina NovaSeq 6000HRS180244 (SAMC1713834)
HRR243901HRR243901_r2.fastq.gz (3.76 GB)HRX202203180501817B2Illumina NovaSeq 6000HRS180244 (SAMC1713834)
HRR243902HRR243902_f1.fastq.gz (1.09 GB)HRX202204180501818B3Illumina NovaSeq 6000HRS180255 (SAMC1713880)
HRR243902HRR243902_r2.fastq.gz (1.13 GB)HRX202204180501818B3Illumina NovaSeq 6000HRS180255 (SAMC1713880)
HRR243903HRR243903_f1.fastq.gz (1.26 GB)HRX202205180501819T3Illumina NovaSeq 6000HRS180266 (SAMC1713924)
HRR243903HRR243903_r2.fastq.gz (1.32 GB)HRX202205180501819T3Illumina NovaSeq 6000HRS180266 (SAMC1713924)
HRR243904HRR243904_f1.fq.gz (4.19 GB)HRX202206180502061B2Illumina NovaSeq 6000HRS180277 (SAMC1713968)
HRR243904HRR243904_r2.fq.gz (4.40 GB)HRX202206180502061B2Illumina NovaSeq 6000HRS180277 (SAMC1713968)
HRR243905HRR243905_f1.fastq.gz (1.11 GB)HRX202207180502062T3Illumina NovaSeq 6000HRS180288 (SAMC1714009)
HRR243905HRR243905_r2.fastq.gz (1.17 GB)HRX202207180502062T3Illumina NovaSeq 6000HRS180288 (SAMC1714009)
Showing 1 to 10 of 120 rows rows per page
Submitter:   Zhu Xiaofan / xfzhu@ihcams.ac.cn
Organization:   Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Submission date:   2021-06-04
Requests:   -